Skip to content

Study Details

ALVR105: A Study Drug for People with Adenoviruses (AdV)

(IRB#: IRB_00153724)

Adenoviruses (AdV) are viruses found in the DNA of a persons body. These viruses may occur from respiratory illnesses, such as a common cold and bronchitis. AdV infections are generally controlled by a persons immune system. People without a strong immune system can experience severe health issues. ALVR105 is a study drug to help people with AdV. Research is needed to learn the safety and effectiveness of the study drug. The information we gain may aid future patients.


  • All genders
  • All Ages
  • Volunteers with special conditions
  •   In Person
  • Paid

Who can participate?

 Gender: All genders

  Age: All Ages

  Volunteers: Volunteers with special conditions

   Location: In Person

Inclusion Criteria

  • Ages 1 year and older
  • AdV diagnosis
  • Agree to use specific birth control during the study
  • In-person at the University of Utah to give informed assent/consent
  • Has an HLA type matching with at least 1 suitably matched and available posoleucel VST line for infusion.

Exclusion Criteria

  • Any health issue that impacts full participation
  • Severe allergy to any part of the study drug or history of severe reaction to blood transfusions
  • COVID-19 diagnosis at time of the study
  • Breast feeding
  • Use of any investigational antiviral agent, including brincidofovir, within 7 days prior to randomization.

Will I be paid for my time?


For more information contact:

Erin Vanderhoof


IRB#: IRB_00153724



Approval Date: 2022-10-26 06:00:00

Specialties: Hematology/BMT, Pediatric Hematology & Oncology

Last Updated: 6/8/23